Public-plan records, documented services and the questions the available sources cannot settle.
What this page answers
Semaglutide for diabetes on the public plan: Step therapy / special authorization (diabetes) for Apotex and Dr. Reddy's generics.
Weight-management products on the public plan: No weight product found other than Imcivree.
Services documented as offered in Alberta: 3 of 7 checked, on the companies' own pages.
Public care route observed: AHS physician or NP referred adult bariatric services.
Evidence depth: moderateDepth describes the research scope, not coverage and not clinical quality.
Public coverage record
Evidence depth: moderateModerate: generic listings and diabetes criteria were read from opened documents; some fields (for example interchangeability) are unknown.
Public plan record for Alberta, as read from the documents named below
Semaglutide for type 2 diabetes (public plan)
Step therapy / special authorization (diabetes) for Apotex and Dr. Reddy's generics; Aspen DINs shown as under review
Weight-management products (public plan)
No weight product found other than Imcivree
Imcivree for rare genetic obesity
Imcivree SA for BBS obesity age 6 and up
Generic interchangeability with Ozempic
Apo 02568012 and Dr. Reddy's 02567814 interchangeable with Ozempic 02471469; Dr. Reddy's 02567806 with Ozempic 02471477; Apo 02568020 not interchangeable; coverage update 1 Jul 2026
Source document date
Interactive Drug Benefit List observed 2026-09-17; record coverage update 2026-07-01
Public care route observed
AHS physician or NP referred adult bariatric services (A-C32)
A listing is not a decision about an individual claim. Criteria, special authorization and the plan's own process still apply.
Services that mention Alberta
Seven services were checked. Each record is what the company's own pages said on the access date.
Documented matches, in alphabetical order
The company's own page names this jurisdiction for its weight service on the access date. Company self-report is not a licence check and not a quality signal.
Weight service list is six provinces. The general platform list adds NS and NL for other categories only; treat NS and NL as explicitly not offered for weight. Territories and QC, NB not named on either list. R22-C02R22-C04R41-C01R41-C02
Recorded state, as written in the data
company self-report: offered
Operator
Felix Inc.; Felix Health Inc. also appears
Initial care fee, as displayed
Main free; funnel $99
Recurring care fee, as displayed
$40 follow-up
Source 2026-09-16 (page said updated yesterday on 2026-09-17)Accessed 2026-09-23
Weight page FAQ says all Canadian provinces. Territories not named. Wording is a blanket statement, not a province-by-province list; keep the label company self-report. R22-C91R41-C51R41-C52
Recorded state, as written in the data
company self-report: offered
Operator
Hims & Hers Canada Inc.
Initial care fee, as displayed
Free in English and French browser views; $99 still in extracted text of both
Recurring care fee, as displayed
Weight-specific fee unknown
Source undated (live page and text extraction differed on consult fee)Accessed 2026-09-23
These records are conflicting, not found in the sources checked, explicitly not offered, not applicable or not researched. They are never mixed in with matches.
Doctor/NP assessment, ongoing reviews and renewals
Conflicting
Three Maple pages disagree. Help page (17 Apr 2026): all locations except NS, NU, NT. Assessment landing page: AB, BC, MB, NB, NL, ON, PEI, QC, SK, Yukon. Obesity page: complimentary assessment in Ontario only. Only ON appears on all three. Display as a dated conflict. R22-C32R22-C33A-C34R41-C19R41-C20R41-C21
Recorded state, as written in the data
conflicting (help page and assessment page name it; obesity page says Ontario only)
Operator
Maple Corporation
Initial care fee, as displayed
Covered by membership (help page); Ontario only per obesity page (conflicting)
Recurring care fee, as displayed
General membership $85/month outside QC; $95/month QC
Referral to specialist; groups and continuing physician support
Not applicable
MSP-covered program for BC residents, virtual or clinic visits, physician referral required. No other province named on checked pages; a BC MSP program is not applicable outside BC. R22-C71R22-C72B-C14aR41-C68
Recorded state, as written in the data
not applicable (BC MSP program)
Operator
Legal operator not found; OMDI/Medical Weight Management branding
No weight-service province or territory list found on the three checked pages. Partner pharmacy is an Ontario corporation (ScaleRx), which does not establish prescribing reach. R22-C98R22-C102R41-C75R41-C76R41-C77
Recorded state, as written in the data
not found in sources checked
Operator
Jack and Jill Health Inc.
Initial care fee, as displayed
$0 initial fee (waived), then $59/month; not a free first month
No weight-specific province list found. Platform terms exclude Quebec and describe pharmacy delivery to provinces and territories; delivery reach is not prescribing reach. Pharmacy operators are in BC and ON. R22-C105R22-C106R22-C111R41-C86R41-C87R41-C88
AHS physician or NP referred adult bariatric services (A-C32)
What this page cannot say yet
Next research step recorded for this jurisdiction: none scheduled; monthly recheck. Recheck assumption: every 30 days for coverage and every 7 days for service pages.
Company self-report: offeredThe company's own page says it offers the service there. This is not a check of licensing or quality.
ConflictingTwo or more of the company's own pages disagree. Both values are shown with their dates.
Not found in sources checkedThe researcher looked and did not find it. This is not the same as not offered.
Explicitly not offeredThe company's page says it does not serve that place.
Not applicableThe service is a public program limited to one province by design.
Not researchedNobody has looked yet.
Sources for this page
Every claim ID below is a row in the evidence ledger. The source date is the date the source itself carries; the access date is when the researcher opened it. A claim with several rows is one claim with several sources, not several confirmations.
This table scrolls sideways.
Source records for every claim cited on this page
Claim
What the source says
Source
Source date
Accessed
Label
A-C22
Alberta semaglutide results show step therapy/special authorization
Alberta semaglutide results list Apo02568012 and02568020 and DrReddy02567806 and02567814 under step therapy/special authorization; Aspen02570912 and02570920 appear under review, not as benefits.
Last Updated field blank in opened web and browser views
2026-09-17
regulator-confirmed
R21-C540
Alberta Imcivree DIN02537745 has Special Authorization coverage for weight management in patients6years or older with clinically/genetically confirmed BBS and obesity; coverage update September1 2025.
